FindTrial
Sign In

Cisatracurium vs Rocuronium: to compare the INTUBATING conditions following these two drugs

A PROSPECTIVE RANDOMISED DOUBLE BLINDED STUDY TO ASSESS THE INTUBATING CONDITIONS OF TWO NON DEPOLARISING MUSCLE RELAXANTS CISATRACURIUM AND ROCURONIUM

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/06/019575
Enrollment
70
Registered
2019-06-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: 0.1 mg/ kg of Inj.Cisatracurium: This group of patients will receive 0.1 mg / kg of Inj.cisatracurium and the intubating conditions are monitored for 30 minutes from the injection of dr

Sponsors

Sri ramachandra university
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Surgeries under general anaesthesia with tracheal intubation following non depolarising muscle relaxants ASA class1 ASA class 2 Elective surgery

Exclusion criteria

Exclusion criteria: ASA class 3 and above Chronic liver disease Chronic kidney disease Age >75 years Obesity > 30 kilograms per metre square Patients with anticipated difficult airway Patients with diseases affecting neuromuscular transmission ( myopathies)

Design outcomes

Primary

MeasureTime frame
Percentage depression of adductor pollicis twitch at 180 secondsTimepoint: Percentage depression of adductor pollicis twitch at 180 seconds—

Secondary

MeasureTime frame
The Copenhagen consensus conference score Heart rate Mean arterial pressure Rare side effectsTimepoint: Preinduction, immediately post induction and after 5 minutes—

Countries

India

Contacts

Public ContactProfessor Mahesh Vakamudi

Sri Ramachandra university

Vakamudi@gmail.com9840022626

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026